| RS2545153722 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545153764 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545153892 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2545154009 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2545154252 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545155962 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545156145 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2545156541 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545162609 |
OBSCN
|
Health Risk |
Pathogenic |
— |
| RS2545172564 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545172930 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545173109 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545173222 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545173475 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545173577 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545173774 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545174190 |
CHD3
|
Health Risk |
Likely pathogenic |
Snijders Blok-Campeau syndrome, Inborn genetic diseases |
| RS2545174628 |
MYO15A
|
Health Risk |
Likely pathogenic |
MYO15A-related disorder, MYO15A-related disorder |
| RS2545176178 |
MYO15A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2545176206 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545176258 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545176812 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545177036 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545177176 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545178918 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545180675 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545180879 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545181239 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545182699 |
SLC25A12
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 39 |
| RS2545184821 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545184852 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545185062 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545185748 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545186890 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545187690 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545187754 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545187885 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545188611 |
MYO15A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2545188753 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545188998 |
SLC25A12
|
Health Risk |
Pathogenic |
— |
| RS2545189511 |
MYO15A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2545189905 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545192559 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545192609 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545193305 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545193475 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545193797 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545194135 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545194243 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545194914 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545195273 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545195353 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545195502 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545196150 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545196328 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2545196394 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545196585 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545197435 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545197666 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545198049 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545199010 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545199408 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2545199633 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545199655 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2545199810 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545200773 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2545200888 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2545200948 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast and/or ovarian cancer, Fanconi anemia complementation group J |
| RS2545201248 |
NBEAL2
|
Health Risk |
Pathogenic |
— |
| RS2545201350 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545202147 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545205316 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545205800 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545206298 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545206952 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545208061 |
SLC25A12
|
Health Risk |
Pathogenic |
— |
| RS2545219953 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545220401 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545221033 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545223678 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545223749 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545224454 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545224702 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545227315 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545228642 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545228941 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545230881 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2545232453 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2545236621 |
ABCB11
|
Health Risk |
Pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545237313 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545242295 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545244528 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545245493 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS2545246000 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545246557 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Cardiovascular phenotype |
| RS2545247153 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545247381 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545247575 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545248405 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545249298 |
ABCB11
|
Health Risk |
Pathogenic |
— |